bromopyruvate has been researched along with Cancer of Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, K; Leonardi, D; Radin, DP | 1 |
| Abd-Allah, AA; Ahmed, AS; Ahmed, NS; Amer, WH; El Sayed, SM; Hamed, AR; Helmy Nabo, MM; Mahmoud, AG; Mohamed, WG; Seddik, MA | 1 |
| Kalyanaraman, B; Komas, SM; Lubet, RA; Pan, J; Wang, Y; You, M; Zhang, Q | 1 |
| Chavez, V; Orue, A; Rieber, M; Strasberg-Rieber, M | 1 |
| Buijs, M; Geschwind, JF; Kutiyanwala, F; Kutiyanwala, M; Syed, L; Vali, M; Vossen, JA | 1 |
| Lubet, RA; North, PE; Pan, J; Wang, Y; Yang, S; You, M; Zhang, Q | 1 |
| Geschwind, JF; Ko, YH; Magee, C; Pedersen, PL; Torbenson, MS | 1 |
1 review(s) available for bromopyruvate and Cancer of Lung
| Article | Year |
|---|---|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
Topics: Acetaminophen; Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glycolysis; Hexokinase; Humans; L-Lactate Dehydrogenase; Lactic Acid; Lung Neoplasms; Male; Melanoma; Necrosis; Neovascularization, Pathologic; Pleural Neoplasms; Prognosis; Pyruvates; Treatment Outcome | 2014 |
6 other study(ies) available for bromopyruvate and Cancer of Lung
| Article | Year |
|---|---|
PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: Involvement of ROS and mitophagy.
Topics: A549 Cells; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Glycolysis; Humans; Lung; Lung Neoplasms; Mitochondria; Mitophagy; Parkinson Disease; Protein Kinases; Pyruvates; Reactive Oxygen Species; Signal Transduction; Ubiquitin-Protein Ligases | 2019 |
Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
Topics: Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Female; Glycolysis; Humans; Lung Neoplasms; Mice; Mice, Inbred A; Mitochondria; Oxygen Consumption; Pyruvates; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.
Topics: A549 Cells; Acetylcysteine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; GTP Phosphohydrolases; Humans; Lung Neoplasms; Melanoma; Membrane Proteins; Mutation; Proto-Oncogene Proteins p21(ras); Pyruvates; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2016 |
Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Topics: Animals; Chemoembolization, Therapeutic; Disease Models, Animal; Hepatectomy; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Lung Neoplasms; Pyruvates; Rabbits | 2008 |
Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Down-Regulation; Drug Evaluation, Preclinical; Female; Humans; Lung Neoplasms; Mice; Models, Biological; Pyruvates | 2012 |
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Embolization, Therapeutic; Injections, Intra-Arterial; Liver Neoplasms, Experimental; Lung Neoplasms; Neoplasm Transplantation; Pyruvates; Rabbits | 2002 |